首页 › 基金 › South Street Advisors LLC › NBIX
South Street Advisors LLC 对 NBIX 的持仓历史
NEUROCRINE BIOSCIENCES INC · 医疗保健
South Street Advisors LLC 在 Q3 2026 的 13F 申报中披露持有 NBIX(NEUROCRINE BIOSCIENCES INC)85,333 股,市值约 US$12.1M,约占其申报组合的 1.59%,在其申报持仓中市值排名第 25 位。 South Street Advisors LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
South Street Advisors LLC 对 NBIX 的持仓演变
South Street Advisors LLC 于 Q3 2026 首次披露 NBIX 持仓:85,333 股(约 US$12.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 85.33K | $12.10M | 新进 |
关于 NBIX 与 13F 数据
NBIX(NEUROCRINE BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 NBIX,申报仓位最大的包括:双西格玛投资 (US$349.9M), 文艺复兴科技 (US$326.3M), Vestal Point Capital, LP (US$316.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NBIX 的基金
- 双西格玛投资 2.08M 股 · $349.92M · Q2 2026
- 文艺复兴科技 2.30M 股 · $326.33M · Q3 2026
- Vestal Point Capital, LP 1.88M 股 · $316.85M · Q2 2026
- RTW INVESTMENTS, LP 1.27M 股 · $213.69M · Q2 2026
更多关于 South Street Advisors LLC
常见问题
How long has South Street Advisors LLC held NBIX?
South Street Advisors LLC has disclosed NBIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is South Street Advisors LLC's current position in NBIX?
As of Q3 2026, South Street Advisors LLC holds 85.33K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $12.10M, representing 1.59% of its reported portfolio and ranking #25.
Has South Street Advisors LLC been buying or selling NBIX?
In the latest 13F filing (Q3 2026), South Street Advisors LLC newly opened its position in NBIX.
Which other funds hold NBIX?
Other major institutional holders of NBIX include 双西格玛投资, 文艺复兴科技, Vestal Point Capital, LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.